Tuaminoheptane

Tuaminoheptane

SCHEMBL353519

CCCCC[C@@H](C)N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tuaminoheptane SCHEMBL354313 1.00
Tuaminoheptane SCHEMBL37510 1.00
SCHEMBL20495963 0.97 OPRM1 (0.94)
Tuaminoheptane SCHEMBL5591367 0.97
SCHEMBL37106 0.97 OPRM1 (0.94)
Tuaminoheptane SCHEMBL23531258 0.97
SCHEMBL20495961 0.97 OPRM1 (0.94)
SCHEMBL20495958 0.97 OPRM1 (0.94)
SCHEMBL20495969 0.97 OPRM1 (0.94)
SCHEMBL20495967 0.97 OPRM1 (0.94)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215047-A1 MUTATED BACTERIAL STRAINS TOLERANT TO ELEVATED CONCENTRATIONS OF AMINES COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2025-10-16 WO claimed
WO-2022088025-A1 APPLICATION OF PANOBINOSTAT IN PREPARING DRUG FOR PREVENTION AND TREATMENT OF CORONAVIRUS 中国科学院深圳先进技术研究院 2022-05-05 WO claimed
WO-2022088037-A1 APPLICATION OF SIRTINOL IN PREPARATION OF DRUG FOR PREVENTING AND TREATING CORONAVIRUS 中国科学院深圳先进技术研究院 2022-05-05 WO claimed
WO-2022088038-A1 APPLICATION OF CAY10603 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING CORONAVIRUS-RELATED DISEASES 中国科学院深圳先进技术研究院 2022-05-05 WO claimed
WO-2022088047-A1 APPLICATION OF ITF2357 IN PREPARATION OF DRUG FOR PREVENTING AND TREATING CORONAVIRUSES 中国科学院深圳先进技术研究院 2022-05-05 WO claimed
CN-112280761-B Recombinant transaminase, mutant of recombinant transaminase and application of mutant 清华大学 2022-04-12 CN claimed
CN-112280761-A Recombinant transaminase, mutant of recombinant transaminase and application of mutant 清华大学 2021-01-29 CN claimed
US-20160000815-A1 COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS GOSFORTH CT HOLDINGS PTY LTD (AU) 2016-01-07 US claimed
US-20140142140-A1 PHARMACEUTICAL COMPOSITION FOR NEUROLOGICAL DISORDERS GOSFORTH CENTRE (HOLDINGS) PTY LTD (AU) 2014-05-22 US claimed
EP-2729216-A1 PHARMACEUTICAL COMPOSITION FOR NEUROLOGICAL DISORDERS Gosforth Centre (Holdings) Pty Ltd (AU) 2014-05-14 EP claimed
WO-2008151170-A2 PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2008-12-11 WO claimed
EP-1987049-A1 AMPHOTERICIN DERIVATIVES ETH Zürich (CH) 2008-11-05 EP claimed
EP-1620442-B1 DICOPPER (I) OXALATE COMPLEXES AS PRECURSOR FOR METALLIC COPPER DEPOSITION BASF SE (DE) 2008-07-23 EP claimed
WO-2007096137-A1 AMPHOTERICIN DERIVATIVES ETH ZURICH (CH) 2007-08-30 WO claimed
EP-1620442-A1 DICOPPER (I) OXALATE COMPLEXES AS PRECURSOR FOR METALLIC COPPER DEPOSITION BASF AKTIENGESELLSCHAFT (DE) 2006-02-01 EP claimed
WO-2004096816-A1 DICOPPER (I) OXALATE COMPLEXES AS PRECURSOR FOR METALLIC COPPER DEPOSITION BASF AKTIENGESELLSCHAFT (DE) 2004-11-11 WO claimed
EP-0987332-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS Kaneka Corporation (JP) 2000-03-22 EP claimed
EP-0341475-B1 STEREO ISOMERS OF N-(R)-1-ARYL-ETHYL)-1-ALKYL-2,2-DICHLOROCYCLOPROPANE CARBOXAMIDE BAYER AG (DE) 1993-09-29 EP claimed
EP-0341475-A2 Stereo isomers of N-(R)-1-aryl-ethyl)-1-alkyl-2,2-dichlorocyclopropane carboxamide BAYER AG (DE) 1989-11-15 EP claimed
US-4129580-A Resolution of certain asymmetric primary amines using lasalocid HOFFMANN-LA ROCHE INC. (US) 1978-12-12 US claimed